Zobrazeno 1 - 10
of 16
pro vyhledávání: '"33"'
Publikováno v:
Langkilde, H, Voss, A, Heegaard, N & Laustrup, H 2017, ' Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up ', Lupus, vol. 26, no. 7, pp. 723-728 . https://doi.org/10.1177/0961203316676378
Background Systemic lupus erythematosus (SLE) is an autoimmune disease with presence of autoantibodies and characteristic multi-organ involvement. Relatives of SLE patients have an increased risk of autoantibody production and autoimmune diseases. Me
Autor:
Micol Frassi, Rossella Reggia, Mara Taraborelli, Marco Taglietti, Angela Tincani, Francesca Dall'Ara, Franco Franceschini, Laura Andreoli
Publikováno v:
Lupus. 23:1255-1258
Objective To assess the prevalence of disease- and therapy-related complications and of the organ damage after a follow-up of 15 years or more in patients with primary antiphospholipid syndrome (PAPS). Methods Medical records of patients prospectivel
Autor:
Ziv Paz, George C. Tsokos, Chau Ching Liu, Borschukova O, Susan Manzi, J M Ahearn, Amy H. Kao, Ionita Ghiran
Publikováno v:
Lupus. 21:1294-1304
The complement system plays an important role in tissue inflammation and damage in SLE patients. High levels of C3d were detected on the surface of erythrocytes and lymphocytes of SLE patients. The objective of this study was to assess the functional
Publikováno v:
Lupus. 14:129-136
The antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL) in patients with thromboembolic complications. In APS, most aPL are autoantibodies to β2-glycoprotein I and prothrombin, which play a major rol
Publikováno v:
Lupus. 13:36-44
The objective of this paper is to investigate the association between patterns of anti-dsDNA antibody isotypes and specific clinical manifestations (categorized in renal, musculoskeletal, cutaneous, hematological, pulmonary, neurologicaland cardiac).
Publikováno v:
Lupus. 12:112-116
Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine t
Publikováno v:
Lupus. 23(10)
Vitamin D has important effects on the immune system as it has been shown to exert antiproliferative and relative immunosuppressant effects. Low levels of this hormone may contribute to the immune activation in systemic lupus erythematosus (SLE) and
Autor:
G Tsariktsian, Ricardo Forastiero, L O Carreras, M M Sturno, B. Alonso, M. E. Martinuzzo, G F de Larrañaga
Publikováno v:
Lupus. 9:594-600
Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b2glycoprotein I (b2GPI) and prothrombin are the main proteins to which autoimmune aPL
Publikováno v:
Lupus. 7:347-354
We measured the serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin) and soluble intercellular adhesion molecule-1 (sICAM-1) in 72 patients with systemic lupus erythematosus (SLE) (including patients w
Autor:
Ola Nived, R.G. Palmer, Gunnar Sturfelt, F.S. Cavalcanti, A. E. Johnson, Caroline Gordon, N.J. Viner, Paul A. Bacon
Publikováno v:
Lupus. 3:501-506
This study is a cross-sectional analysis of the differences between SLE outpatients seen in Rheumatology departments at University centres in England, Brazil and Sweden, using a standard protocol. The demographic characteristics, extent and activity